| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Head, Neck, and Thoracic Medical Oncology [Y. H. L. R. P.] and Clinical Investigations [W. P.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
The effect of the topoisomerase II inhibitor doxorubicin and its noncross-resistant analogue annamycin on DNA degradation and programmed cell death was examined in murine leukemia P388 cells. P388 parental cells exposed to various concentrations of doxorubicin and annamycin for 24 h displayed dose-dependent DNA cleavage: at 1 µM, both doxorubicin and annamycin were effective in inducing DNA breakdown, but at 10 µM, the effect was markedly decreased or totally absent. In multidrug-resistant P388/Dox cells, doxorubicin did not cause DNA cleavage, while 10 µM annamycin had a significant effect. By agarose gel analysis, drug-induced DNA fragmentation showed the characteristic pattern of internucleosomal ladder. Morphologically, P388 cells treated with 1 µM doxorubicin or annamycin for 24 h showed a reduction in cell volume and condensation of nuclear structures. Similar changes were observed in P388/Dox cells exposed to 10 µM annamycin for 24 h but not in cells exposed to 10 µM doxorubicin. Time course studies demonstrated that DNA fragmentation was detected 12 h after incubation with 1 µM doxorubicin or annamycin, while loss of membrane integrity appeared at 24 h, thus indicating that DNA degradation was a preceding event. DNA fragmentaton caused by doxorubicin and annamycin was inhibited by the RNA synthesis inhibitor actinomycin D, the protein synthesis inhibitor cycloheximide, and the endonuclease inhibitor aurintricarboxylic acid. Drug-induced cell death was partially prevented by cycloheximide and aurintricarboxylic acid, thus suggesting that the apoptotic process caused by these drugs requires gene expression, synthesis of new proteins, and activation of endogenous nucleases. In contrast, DNA cleavage was not affected by incubating cells with 1 mM ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, thus indicating that intracellular calcium depletion does not affect anthracycline-induced apoptosis. The results obtained demonstrate that the cell killing effect of anthracyclines is mediated, at least in part, by the induction of apoptosis.
1 Supported in part by NIH Grant CA50270 and Argus Pharmaceutical, Inc.
2 To whom requests for reprints should be addressed, at Department of Head, Neck, and Thoracic Medical Oncology, Box 80, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 10/ 7/92. Accepted 1/18/93.
This article has been cited by other articles:
![]() |
G. Gausdal, B. T. Gjertsen, E. McCormack, P. Van Damme, R. Hovland, C. Krakstad, O. Bruserud, K. Gevaert, J. Vandekerckhove, and S. O. Doskeland Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death Blood, March 1, 2008; 111(5): 2866 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hassan, S. Islam, M. M. Mu, H. Ito, N. Koide, I. Mori, T. Yoshida, and T. Yokochi Lipopolysaccharide Prevents Doxorubicin-Induced Apoptosis in RAW 264.7 Macrophage Cells by Inhibiting p53 Activation Mol. Cancer Res., July 1, 2005; 3(7): 373 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Trevino, B. A. Woynarowska, T. S. Herman, W. Priebe, and J. M. Woynarowski Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues Mol. Cancer Ther., November 1, 2004; 3(11): 1403 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, W. Li, J. Su, W. Liu, B. T. Altura, and B. M. Altura Peroxynitrite Induces Apoptosis in Rat Aortic Smooth Muscle Cells: Possible Relation to Vascular Diseases Experimental Biology and Medicine, March 1, 2004; 229(3): 264 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Elmore, C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction J. Biol. Chem., September 13, 2002; 277(38): 35509 - 35515. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Ling, L. Liebes, B. Ng, M. Buckley, P. J. Elliott, J. Adams, J.-D. Jiang, F. M. Muggia, and R. Perez-Soler PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G2-M Phase Arrest and Apoptosis Mol. Cancer Ther., August 1, 2002; 1(10): 841 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Carter, M. Milella, D. C. Altieri, and M. Andreeff Cytokine-regulated expression of survivin in myeloid leukemia Blood, May 1, 2001; 97(9): 2784 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Ling, Y. Zhong, and R. Perez-Soler Disruption of Cell Adhesion and Caspase-Mediated Proteolysis of {beta}- and {gamma}-Catenins and APC Protein in Paclitaxel-Induced Apoptosis Mol. Pharmacol., March 1, 2001; 59(3): 593 - 603. [Abstract] [Full Text] |
||||
![]() |
O. J. Arola, A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen, and L.-M. Voipio-Pulkki Acute Doxorubicin Cardiotoxicity Involves Cardiomyocyte Apoptosis Cancer Res., April 1, 2000; 60(7): 1789 - 1792. [Abstract] [Full Text] |
||||
![]() |
N. J. Donato, M. Perez, H. Kang, Z. H. Siddik, Y.-H. Ling, and R. Perez-Soler EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity Clin. Cancer Res., January 1, 2000; 6(1): 193 - 202. [Abstract] [Full Text] |
||||
![]() |
E. Delpy, S. N Hatem, N. Andrieu, C. de Vaumas, M. Henaff, C. Rucker-Martin, J.-P. Jaffrezou, G. Laurent, T. Levade, and J.-J. Mercadier Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes Cardiovasc Res, August 1, 1999; 43(2): 398 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Ling, C. Tornos, and R. Perez-Soler Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, H. Yoshitomi, H. Ishida, H. Kuromi, J. Kawaki, Y. Seino, and S. Seino Altered bcl-2 and bax Expression and Intracellular Ca2+ Signaling in Apoptosis of Pancreatic Cells and the Impairment of Glucose-Induced Insulin Secretion Endocrinology, March 1, 1998; 139(3): 1429 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Los, I. Herr, C. Friesen, S. Fulda, K. Schulze-Osthoff, and K.-M. Debatin Cross-Resistance of CD95- and Drug-Induced Apoptosis as a Consequence of Deficient Activation of Caspases (ICE/Ced-3 Proteases) Blood, October 15, 1997; 90(8): 3118 - 3129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |